Anticancer effects of diallyl trisulfide derived from garlic

Asia Pacific Journal of Clinical Nutrition

Volumn 17, Issue SUPPL. 1, 2008, Pages 249-252

  Seki, Taiichiro ^a   Hosono, Takashi ^a   Hosono Fukao, Tomomi ^a   Inada, Kahoru ^a   Tanaka, Rie ^a   Ogihara, Jun ^a   Ariga, Toyohiko ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cancer; Diallyl trisulfide; Garlic; Tubulin

Indexed keywords

ALLIUM SATIVUM;

ALLYL COMPOUND; ANTINEOPLASTIC AGENT; DIALLYL TRISULFIDE; SULFIDE;

APOPTOSIS; CELL CYCLE; CHEMISTRY; DRUG EFFECT; GARLIC; HUMAN; MICROTUBULE; NEOPLASM; REVIEW; TUMOR CELL LINE; ULTRASTRUCTURE;

ALLYL COMPOUNDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; GARLIC; HUMANS; MICROTUBULES; NEOPLASMS; SULFIDES;

EID: 46049097420     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ariga T, Oshiba S, Tamada T. Platelet aggregation inhibitor in garlic. Lancet. 1981;1:150-1.
2. Ariga T, Seki T. Antithrombotic and anticancer effects of garlic-derived sulfur compounds: a review. Biofactors. 2006;26:93-103.
3. Ariga T, Seki T. Functional Foods from Garlic and Onion. In: Shi J, Ho CT, Shahidi F, editors. Asian Functional Foods. New York: CRC Press, 2005. p. 433-490.
4. Fukao T, Hosono T, Misawa S, Seki T, Ariga T. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. Food Chem Toxicol. 2004;42:743-9.
5. Milner JA. A historical perspective on garlic and cancer. J Nutr. 2001; 131(3s): 1027S-31S.
6. Fleischauer AT, Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J Nutr. 2001;131:1032S-40S.
7. Hosono T, Fukao T, Ogihara J, Ito Y, Shiba H, Seki T, Ariga T. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of β-tubulin. J Biol Chem. 2005;280:41487-93.
8. Ling YH, Jiang JD, Holland JF, Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol. 2002;62:529-38.
9. Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Cancer Res. 2004;64:4621-8.
10. Islam MN, Iskander MN. Microtubulin binding sites as target for developing anticancer agents. Mini Rev Med Chem. 2004;4:1077-104.
11. Gupta S, Bhattacharyya B. Antimicrotubular drugs binding to vinca domain of tubulin. Mol Cell Biochem. 2003;253:41-7.